PainReform is headquartered in Tel Aviv, Israel.
PainReform disclosed revenue of 10M USD for 2023 and 9M USD for 2022.
PainReform has 2 employees.
PainReform is a life science company.
PainReform was founded in 2007.
65 Yigal Alon Street,
Tel Aviv,
6744316
Israel,
+972 3 717 7050
www.painreform.com
PainReform is a specialty pharmaceutical company that engages in the development of products for the treatment of pain in Israel. The company develops PRF-110, a product based on local anesthetic ropivacaine, which completed Phase II clinical study in hernia repair. PainReform was founded in 2007 and is based in Tel Aviv, Israel.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | - | - | - | - | 2 | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
